INVO Fertility (IVF) EBT Margin (2011 - 2026)
INVO Fertility's (IVF) quarterly EBT Margin came in at 86.73% in Q1 2026, up 97629.0% year-on-year from N/an in Q1 2025, and up 42.38% on a QoQ basis from 150.51% in Q3 2025.
INVO Fertility (IVF) EBT Margin (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has 16 years of EBT Margin data on file, last reported at 86.73% in Q1 2026.
- On a quarterly basis, EBT Margin rose 97629.0% year-over-year to 86.73% in Q1 2026; TTM through Mar 2026 was 343.8%, a 3430.0% increase from a year earlier, with the FY2024 full-year figure at 139.6%, up 12548.0% from the prior year.
- EBT Margin for Q1 2026 stood at 86.73%, up from 150.51% in the prior quarter.
- Over the last five years, EBT Margin for IVF reached as high as 86.73% in Q1 2026 and fell as low as 1916.54% in Q2 2022.
- Historically, EBT Margin has averaged 596.57% across 5 years, with a median of 195.16% in 2024.
- Across the five-year window, EBT Margin tumbled 145505 bps in 2022 and soared 120821 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 994.08% in 2022, then soared by 86 bps to 142.7% in 2023, then plunged by 53 bps to 218.12% in 2024, then surged by 31 bps to 150.51% in 2025, then soared by 42 bps to 86.73% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 86.73% in Q1 2026, 150.51% in Q3 2025, and 172.19% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | -86.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.73% |
| Sep 30, 2025 | -150.51% |
| Jun 30, 2025 | -172.19% |
| Mar 31, 2025 | -1,063.02% |
| Dec 31, 2024 | -218.12% |
| Sep 30, 2024 | -111.74% |
| Jun 30, 2024 | -122.25% |
| Mar 31, 2024 | -101.17% |
| Dec 31, 2023 | -142.70% |
| Sep 30, 2023 | -127.87% |
| Jun 30, 2023 | -708.34% |
| Mar 31, 2023 | -732.96% |
| Dec 31, 2022 | -994.08% |
| Sep 30, 2022 | -1,083.47% |
| Jun 30, 2022 | -1,916.54% |
| Mar 31, 2022 | -1,813.47% |
| Dec 31, 2021 | 3.34% |
| Sep 30, 2021 | -1,133.68% |
| Jun 30, 2021 | -871.66% |
| Mar 31, 2021 | -358.42% |